Monday, July 12, 2021

Tatva Chintan Pharma Receives Sebi Nod For Rs 450 crore IPO

Tatva Chintan Pharma IPO: The IPO will consist of fresh issuance of shares worth Rs 225 crore and an offer of sale worth Rs 225 crore by existing promoters and shareholders

from NDTV Profit - Latest https://ift.tt/3e6mGeI
via
-
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)